Douglas Gladstone, MD
Northwell Health recently appointed Douglas Gladstone, MD, a leader in hematology and medical oncology, as Chief of Hematologic Malignancies at the Northwell Health Cancer Institute. Prior to joining Northwell, Dr. Gladstone served for 14 years as Clinical Director of the outpatient bone marrow transplantation program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore.
Looking Ahead
“We are thrilled Dr. Gladstone has joined Northwell’s Cancer Institute to lead the Division of Hematologic Malignancies across our health system in the New York metropolitan region,” said Richard Barakat, MD, Physician-in-Chief and Director of the Northwell Health Cancer Institute, and Senior Vice President of Cancer Services at Northwell Health. “His more than 2 decades of clinical expertise, cutting-edge research, and academic teaching in the field of blood cancers and benign blood disorders will be a tremendous asset at the Cancer Institute as we advance programs and drive innovative approaches for cancer treatments.”
At the Cancer Institute, Dr. Gladstone will help establish an outpatient hematopoietic and cellular transplantation center at Northwell, broaden the use of chimeric antigen receptor T-cell therapy, and explore the role of transplanting regulatory T cells.
“Among my key goals will be to collaborate with my colleagues to unify hematology care across the health system as well as help lead efforts for the Northwell Cancer Institute to earn National Cancer Institute (NCI) designation, which recognizes cancer centers for their scientific leadership in laboratory and clinical research, as well as serving their communities and promoting and training a range of health-care professionals,” Dr. Gladstone said.
In addition, Dr. Gladstone will partner with Cancer Institute leadership to further advance faculty engagement in clinical research recruitment and catalyze new clinical and translational research initiatives. He will work collaboratively with leadership to improve process and flow within the outpatient R.J. Zuckerberg Cancer Center to support efficiencies, develop programmatic growth, and oversee the future transfer of the bone marrow transplantation and leukemia units from North Shore University Hospital in Manhasset to the R.J. Zuckerberg Cancer Hospital at Long Island Jewish Medical Center in New Hyde Park.
